[{"address1": "6550 South Millrock Drive", "address2": "Suite G50", "city": "Salt Lake City", "state": "UT", "zip": "84121", "country": "United States", "phone": "801 676 9695", "website": "https://clene.com", "industry": "Packaged Foods", "industryKey": "packaged-foods", "industryDisp": "Packaged Foods", "sector": "Consumer Defensive", "sectorKey": "consumer-defensive", "sectorDisp": "Consumer Defensive", "longBusinessSummary": "Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Etherington MBA", "age": 57, "title": "CEO, President & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 982088, "exercisedValue": 0, "unexercisedValue": 1333}, {"maxAge": 1, "name": "Mr. Morgan R. Brown CPA, M.B.A.", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 593204, "exercisedValue": 0, "unexercisedValue": 533}, {"maxAge": 1, "name": "Mr. Mark G. Mortenson ESQ.", "age": 66, "title": "Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 724057, "exercisedValue": 0, "unexercisedValue": 1333}, {"maxAge": 1, "name": "Mr. Jerry  Miraglia J.D.", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary Anne Mcneil", "title": "Head of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael T. Hotchkin", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Benjamin M. Greenberg M.D., M.H.S.", "title": "Head of Medical", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.3, "open": 7.05, "dayLow": 6.6025, "dayHigh": 8.91, "regularMarketPreviousClose": 7.3, "regularMarketOpen": 7.05, "regularMarketDayLow": 6.6025, "regularMarketDayHigh": 8.91, "payoutRatio": 0.0, "beta": 0.773, "forwardPE": -2.4135978, "volume": 217151, "regularMarketVolume": 217151, "averageVolume": 132544, "averageVolume10days": 172170, "averageDailyVolume10Day": 172170, "bid": 9.43, "ask": 8.74, "bidSize": 1, "askSize": 1, "marketCap": 85796152, "fiftyTwoWeekLow": 2.28, "fiftyTwoWeekHigh": 13.5, "allTimeHigh": 356.4, "allTimeLow": 2.28, "priceToSalesTrailing12Months": 299.98654, "fiftyDayAverage": 8.1242, "twoHundredDayAverage": 4.91155, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 86492144, "profitMargins": 0.0, "floatShares": 7174427, "sharesOutstanding": 10069970, "sharesShort": 279974, "sharesShortPriorMonth": 312601, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0278, "heldPercentInsiders": 0.30835, "heldPercentInstitutions": 0.18462, "shortRatio": 1.77, "shortPercentOfFloat": 0.0424, "impliedSharesOutstanding": 10069970, "bookValue": -1.095, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -29705000, "trailingEps": -3.78, "forwardEps": -3.53, "lastSplitFactor": "1:20", "lastSplitDate": 1720656000, "enterpriseToRevenue": 302.42, "enterpriseToEbitda": -3.484, "52WeekChange": 0.6590909, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 8.52, "targetHighPrice": 48.0, "targetLowPrice": 20.0, "targetMeanPrice": 30.42857, "targetMedianPrice": 30.0, "recommendationMean": 1.14286, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 7285000, "totalCashPerShare": 0.729, "ebitda": -24829000, "totalDebt": 20846000, "quickRatio": 1.136, "currentRatio": 1.582, "totalRevenue": 286000, "revenuePerShare": 0.034, "returnOnAssets": -0.52858, "grossProfits": 230000, "freeCashflow": -7821875, "operatingCashflow": -17643000, "revenueGrowth": -0.703, "grossMargins": 0.8042, "ebitdaMargins": 0.0, "operatingMargins": -217.1852, "financialCurrency": "USD", "symbol": "CLNN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1539869400000, "cryptoTradeable": false, "regularMarketChangePercent": 16.7123, "regularMarketPrice": 8.52, "shortName": "Clene Inc.", "longName": "Clene Inc.", "corporateActions": [], "postMarketTime": 1763160560, "regularMarketTime": 1763154002, "exchange": "NCM", "messageBoardId": "finmb_339429732", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": -1.9953059, "postMarketPrice": 8.35, "postMarketChange": -0.17000008, "regularMarketChange": 1.22, "regularMarketDayRange": "6.6025 - 8.91", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 132544, "fiftyTwoWeekLowChange": 6.2400007, "fiftyTwoWeekLowChangePercent": 2.7368424, "fiftyTwoWeekRange": "2.28 - 13.5", "fiftyTwoWeekHighChange": -4.9799995, "fiftyTwoWeekHighChangePercent": -0.36888885, "fiftyTwoWeekChangePercent": 65.90909, "earningsTimestampStart": 1755088200, "earningsTimestampEnd": 1755088200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.78, "epsForward": -3.53, "epsCurrentYear": -2.13667, "priceEpsCurrentYear": -3.9875133, "fiftyDayAverageChange": 0.3958006, "fiftyDayAverageChangePercent": 0.048718717, "twoHundredDayAverageChange": 3.6084504, "twoHundredDayAverageChangePercent": 0.7346867, "priceToBook": -7.7808223, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Clene Nanomedicine Inc.", "nameChangeDate": "2025-11-14", "averageAnalystRating": "1.1 - Strong Buy", "displayName": "Clene", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]